Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun;27(2):199-208.
doi: 10.1055/s-0030-1253518.

Osteoplasty: Percutaneous Bone Cement Injection beyond the Spine

Giovanni Carlo Anselmetti  1
Affiliations

Osteoplasty: Percutaneous Bone Cement Injection beyond the Spine

Giovanni Carlo Anselmetti. Semin Intervent Radiol. 2010 Jun.

Abstract

Percutaneous osteoplasty, the injection of bone cement into a painful bone lesion refractory to conventional therapy (radiotherapy, chemotherapy, and narcotic analgesia), is performed to allow for immediate bone structure consolidation, reduce the risk of a pathological fracture, achieve pain regression, and improve mobility. In this article, the technique of this procedure and a review of the current literature including the author's personal large series will be described.

Keywords: Osteoplasty; cement; percutaneous; spine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The most adequate approach can be identified by placing a metallic radiopaque marker on the skin; distance from the entry point to the center of the lesion can be measured.
Figure 2
Figure 2
After needle insertion, computed tomography scan demonstrates the correct needle position inside the lesion.
Figure 3
Figure 3
After osteoplasty, a computed tomography scan of the treated region assesses the extent of lesion filling and visualizes possible polymethyl methacrylate leaks or complications.
Figure 4
Figure 4
More than one lesion (arrows) can be treated in the same session.
See this image and copyright information in PMC

References

    1. Dewar J A. Managing metastatic bone pain. BMJ. 2004;329:812–813. - PMC - PubMed
    1. Roos D E, Fisher R J. Radiotherapy for painful bone metastases: an overview of the overviews. Clin Oncol (R Coll Radiol) 2003;15:342–344. - PubMed
    1. Ross J R, Saunders Y, Edmonds P M, Patel S, Broadley K E, Johnston S R. Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer. BMJ. 2003;327:469. - PMC - PubMed
    1. Rosen L S, Gordon D, Tchekmedyian N S, et al. Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, phase III, double-blind, placebo-controlled trial. Cancer. 2004;100:2613–2621. - PubMed
    1. Saad F, Gleason D M, Murray R, et al. Zoledronic Acid Prostate Cancer Study Group Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Cancer Inst. 2004;96:879–882. - PubMed